| Authors: |
Westley RL; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, United Kingdom; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, United Kingdom., Daamen LA; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Teunissen FR; Department of Radiotherapy, Radboud University Medical Center, Nijmegen, the Netherlands., Vesprini D; Department of Radiation Oncology, Sunnybrook Health Sciences Centre-Odette Cancer Centre, Toronto, Ontario, Canada., Choudhury A; Department of Clinical Oncology, The University of Manchester, Manchester, United Kingdom., Pos FJ; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Verkooijen HM; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht, the Netherlands., Fuller CD; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Choi S; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, USA., Hall WA; Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., van der Voort van Zyp JRN; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands., Christodouleas JP; Elekta AB, Stockholm, Sweden; Department of Radiation Oncology, Hospital of the University of Pennsylvania, Philadelphia, USA., Tree AC; Department of Radiotherapy, The Royal Marsden NHS Foundation Trust, London, United Kingdom; Division of Radiotherapy and Imaging, The Institute of Cancer Research, Sutton, United Kingdom. |
